FluoretiQ
At FluoretiQ, we are building the next generation of point of care diagnostic technology to combat antimicrobial resistance.
Our mission is simple, yet profound: to make diagnosing bacterial infections faster, smarter, and more accessible. This resolves a decades long challenge of making the first antibiotic prescription, the right prescription; saving time, saving lives, and ultimately, saving antibiotics.
FluoretiQ specialises in growth-free, machine-learning powered, point-of-care tests that deliver results in minutes. Its patented technologies, VERI-5® and SCFI™, detect bacterial infections and antibiotic sensitivity directly from samples—reducing the current 3-day process to minutes. FluoretiQ has achieved over 90% accuracy testing with over 600 samples from humans and animals.
FluoretiQ has built a team that combines deep technical expertise and established leaders with commercial, clinical and operational experience. With active collaborations across academia, veterinary and human health, FluoretiQ is uniquely positioned to drive antimicrobial stewardship and tackle the global Antimicrobial Resistance (AMR) crisis.
Website: https://www.fluoretiq.com